Harrow, Inc. (HROW)
26.04
-2.71
(-9.43%)
USD |
NASDAQ |
Nov 05, 16:00
26.10
+0.06
(+0.23%)
After-Hours: 05:02
Harrow Net Income (TTM) : -37.23M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -37.23M |
| March 31, 2026 | -14.96M |
| December 31, 2025 | -5.139M |
| September 30, 2025 | -4.988M |
| June 30, 2025 | -10.23M |
| March 31, 2025 | -21.70M |
| December 31, 2024 | -17.48M |
| September 30, 2024 | -33.41M |
| June 30, 2024 | -33.58M |
| March 31, 2024 | -31.33M |
| December 31, 2023 | -24.41M |
| September 30, 2023 | -14.21M |
| June 30, 2023 | -16.28M |
| March 31, 2023 | -18.29M |
| December 31, 2022 | -14.09M |
| September 30, 2022 | -22.56M |
| June 30, 2022 | -24.42M |
| March 31, 2022 | -20.66M |
| December 31, 2021 | -18.01M |
| September 30, 2021 | -9.448M |
| June 30, 2021 | 7.503M |
| March 31, 2021 | 9.721M |
| December 31, 2020 | -3.419M |
| September 30, 2020 | -1.968M |
| June 30, 2020 | -22.22M |
| Date | Value |
|---|---|
| March 31, 2020 | -24.38M |
| December 31, 2019 | -0.125M |
| September 30, 2019 | 15.41M |
| June 30, 2019 | 24.53M |
| March 31, 2019 | 29.47M |
| December 31, 2018 | 14.62M |
| September 30, 2018 | -6.276M |
| June 30, 2018 | -9.454M |
| March 31, 2018 | -10.49M |
| December 31, 2017 | -11.98M |
| September 30, 2017 | -15.32M |
| June 30, 2017 | -13.47M |
| March 31, 2017 | -19.60M |
| December 31, 2016 | -19.09M |
| September 30, 2016 | -18.11M |
| June 30, 2016 | -18.21M |
| March 31, 2016 | -17.30M |
| December 31, 2015 | -15.90M |
| September 30, 2015 | -13.52M |
| June 30, 2015 | -12.02M |
| March 31, 2015 | -10.89M |
| December 31, 2014 | -10.12M |
| September 30, 2014 | -9.255M |
| June 30, 2014 | -8.880M |
| March 31, 2014 | -8.503M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Viatris, Inc. | -- |
| 60 Degrees Pharmaceuticals, Inc. | -8.104M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 159.33M |
| Veru, Inc. | -14.11M |